Eagle Asset Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $45.4M | Sell |
|
|||||
|
2022
Q3 | $41M | Buy |
|
|||||
|
2022
Q2 | $44.3M | Buy |
|
|||||
|
2022
Q1 | $43.9M | Sell |
|
|||||
|
2021
Q4 | $112M | Buy |
|
|||||
|
2021
Q3 | $122M | Buy |
|
|||||
|
2021
Q2 | $74.1M | Sell |
|
|||||
|
2021
Q1 | $59.9M | Buy |
|
|||||
|
2020
Q4 | $48.3M | Buy |
|
|||||
|
2020
Q3 | $32M | Buy |
|
|||||
|
2020
Q2 | $2.04M | Sell |
|
|||||
|
2020
Q1 | $5.09M | Sell |
|
|||||
|
2019
Q4 | $6.2M | Sell |
|
|||||
|
2019
Q3 | $5.79M | Sell |
|
|||||
|
2019
Q2 | $7.45M | Sell |
|
|||||
|
2019
Q1 | $8.5M | Sell |
|
|||||
|
2018
Q4 | $7.12M | Buy |
|
|||||
|
2018
Q3 | $8.45M | Buy |
|
|||||
|
2018
Q2 | $3.48M | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $39.9M | Buy |
|
|||||
|
2017
Q3 | $35M | Buy |
|
|||||
|
2017
Q2 | $30.9M | Buy |
|
|||||
|
2017
Q1 | $26.3M | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $3.5M | Buy |
|
|||||
|
2013
Q3 | $2.66M | Buy |
|
|||||
|
2013
Q2 | $1.94M | Buy |
|